Summary
Signal counts
Assets tracked: 1
Watchlist assets: 1
Registry stop assets: 0
Sponsor overview
Grupo Español de Investigación en Cáncer de Ovario
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT03470805 | https://clinicaltrials.gov/study/NCT04417062
Assets
Linked programs
- Olaparib: Results Not Found Signal (4/5)